Sort
11,323 grants matching “glioblastoma”
Project 2: Clinical evaluation of a novel oHSV in recurrent human GBM
$339,665E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2018 · CA
SON-mediated RNA splicing in glioblastoma
$339,622Erin Eun-Young Ahn · University Of Alabama At Birmingham · R01 · FY2024 · CA
Interplay between ubiquitination and epigenetic regulation of EGFR signaling in gliomagenesis
$339,609Suyun Huang · Virginia Commonwealth University · R01 · FY2020 · NS
Interplay between ubiquitination and epigenetic regulation of EGFR signaling in gliomagenesis
$339,609Suyun Huang · Virginia Commonwealth University · R01 · FY2021 · NS
Interplay between ubiquitination and epigenetic regulation of EGFR signaling in gliomagenesis
$339,609Suyun Huang · Virginia Commonwealth University · R01 · FY2019 · NS
Screening for modulators of glioma stem cells differentiation
$339,553Bakhos A. Tannous · Massachusetts General Hospital · R01 · FY2013 · CA
Chemical Probes Targeting Gliomas with IDH Mutation
$339,511Yongcheng Song · Baylor College Of Medicine · R01 · FY2014 · NS
Tissue-Engineered Models of Microvessel-Mediated Glioblastoma Invasion
$339,463Stephanie Kristin Seidlits · University Of California Los Angeles · R01 · FY2021 · CA
Targeting Radiation-Induced Glioblastoma Invasion
$339,436Satoru Osuka · University Of Alabama At Birmingham · R01 · FY2025 · NS
Project 1: Neural Stem Cell Based Oncolytic Virotherapy of Malignant Glioma
$339,278Maciej S Lesniak · Northwestern University At Chicago · P50 · FY2020 · CA
Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach
$339,253Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Project 1: Arming Oncolytic HSV Vectors to Improve Virolysis in Syngeneic Mouse Models of GBM
$339,204Joseph C. Glorioso · Brigham And Women'S Hospital · P01 · FY2020 · CA
Therapy Evaluation Core
$339,198Jann N Sarkaria · Mayo Clinic Rochester · U19 · FY2023 · CA
Reversal of CMV-specific immune deficits in patients with glioblastoma
$339,185Duane A. Mitchell · Duke University · R01 · FY2009 · NS
The Heterogeneity of Glioblastoma Multiforme and its Applications towards the Dev
$339,145Paul S Mischel · California Institute Of Technology · U54 · FY2013 · CA
Inhibition of glioma tumor growth by antisense MMP-9
$339,063Jasti S Rao · University Of Illinois At Chicago · R01 · FY2008 · NS
Inhibition of glioma tumor growth by antisense MMP-9
$339,063Jasti S Rao · University Of Illinois At Chicago · R01 · FY2007 · NS
Dual Targeting of Brain Tumor Initiating Cells through Inhibition of BMI1 and EZH2
$339,063Jeremy N Rich · University Of California, San Diego · R01 · FY2018 · NS
Dual Targeting of Brain Tumor Initiating Cells through Inhibition of BMI1 and EZH2
$339,063Jeremy N Rich · University Of California, San Diego · R01 · FY2017 · NS
Dual Targeting of Brain Tumor Initiating Cells through Inhibition of BMI1 and EZH2
$339,063Jeremy N Rich · University Of California, San Diego · R01 · FY2019 · NS
Inhibition of glioma tumor growth by antisense MMP-9
$339,063Jasti S Rao · University Of Illinois At Chicago · R01 · FY2009 · NS
Targeting Mechanisms of Acquired Temozolomide Resistance in Glioblastoma
$339,063Clark Chin-Chung Chen · University Of California, San Diego · R01 · FY2016 · NS
Targeting Mechanisms of Acquired Temozolomide Resistance in Glioblastoma
$339,063Clark Chin-Chung Chen · University Of California, San Diego · R01 · FY2017 · NS
Core 1: Tumor Processing and Single Cell RNA sequencing Core
$339,055Kai W Wucherpfennig · Brigham And Women'S Hospital · P01 · FY2024 · CA
The role of ICOSL in renal protection
$339,035Eunsil Hahm · Rush University Medical Center · R01 · FY2024 · DK